This approach augments NKG2D-CAR-T cell efficacy within the pancreatic tumor microenvironment, enhancing their activation, degranulation, cytokine production, and cytotoxicity against IL-4-expressing pancreatic cancer cells. This evidence concerns the gene KLRK1 and pancreatic neoplasm.